229 views
Photo from URA

URA, MoH receive 4 tender submissions for Parry Avenue site

The tender for the site closed on 21 March.

The tender for the site at Parry Avenue for a private assisted living development closed on 21 March with four submissions.

The Urban Redevelopment Authority (URA) and the Ministry of Health (MoH) received tenders from Evia Real Estate (I) Pte Ltd, Allium Healthcare Holdings Pte Ltd, Yuan Ching group, United Medicare Development, and two separate submissions from Pre 20 Pte. Ltd.

URA and MoH launched the Parry Avenue site for sale via a Concept and Price Revenue tender on 29 September 2022.

Tenderers submitted their concept proposals and tender prices separately.

Only shortlisted concept proposals that are shortlisted will proceed to the second stage of evaluation, which will be based only on price. 

"The site will then be awarded to the shortlisted tenderer with the highest bid price,” the URA said.
 

Follow the links for more news on

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare